Global Pneumoconiosis Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 39108

Pneumoconiosis is an occupational lung disease and a restrictive lung disease caused by the inhalation of dust, often in mines and from agriculture.
In 2013 pneumoconiosis resulted in 260,000 deaths up from 251,000 deaths in 1990. Of these deaths 46,000 were due to silicosis, 24,000 due to asbestosis and 25,000 due to coal workers pneumoconiosis.
In 2018, the global Pneumoconiosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pneumoconiosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pneumoconiosis development in United States, Europe and China.

The key players covered in this study
Novartis
Abbott
Eli Lilly
Sunpharma
Sanofi
Novo Nordisk
AstraZeneca
...

Market segment by Type, the product can be split into
Asbestosis
Berylliosis
Byssinosis
Coal Workers Pneumoconiosis
Silicosis

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pneumoconiosis status, future forecast, growth opportunity, key market and key players.
To present the Pneumoconiosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pneumoconiosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pneumoconiosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Asbestosis
1.4.3 Berylliosis
1.4.4 Byssinosis
1.4.5 Coal Workers Pneumoconiosis
1.4.6 Silicosis
1.5 Market by Application
1.5.1 Global Pneumoconiosis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pneumoconiosis Market Size
2.2 Pneumoconiosis Growth Trends by Regions
2.2.1 Pneumoconiosis Market Size by Regions (2014-2025)
2.2.2 Pneumoconiosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pneumoconiosis Market Size by Manufacturers
3.1.1 Global Pneumoconiosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Pneumoconiosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pneumoconiosis Market Concentration Ratio (CR5 and HHI)
3.2 Pneumoconiosis Key Players Head office and Area Served
3.3 Key Players Pneumoconiosis Product/Solution/Service
3.4 Date of Enter into Pneumoconiosis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pneumoconiosis Market Size by Type (2014-2019)
4.2 Global Pneumoconiosis Market Size by Application (2014-2019)

5 United States
5.1 United States Pneumoconiosis Market Size (2014-2019)
5.2 Pneumoconiosis Key Players in United States
5.3 United States Pneumoconiosis Market Size by Type
5.4 United States Pneumoconiosis Market Size by Application

6 Europe
6.1 Europe Pneumoconiosis Market Size (2014-2019)
6.2 Pneumoconiosis Key Players in Europe
6.3 Europe Pneumoconiosis Market Size by Type
6.4 Europe Pneumoconiosis Market Size by Application

7 China
7.1 China Pneumoconiosis Market Size (2014-2019)
7.2 Pneumoconiosis Key Players in China
7.3 China Pneumoconiosis Market Size by Type
7.4 China Pneumoconiosis Market Size by Application

8 Japan
8.1 Japan Pneumoconiosis Market Size (2014-2019)
8.2 Pneumoconiosis Key Players in Japan
8.3 Japan Pneumoconiosis Market Size by Type
8.4 Japan Pneumoconiosis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pneumoconiosis Market Size (2014-2019)
9.2 Pneumoconiosis Key Players in Southeast Asia
9.3 Southeast Asia Pneumoconiosis Market Size by Type
9.4 Southeast Asia Pneumoconiosis Market Size by Application

10 India
10.1 India Pneumoconiosis Market Size (2014-2019)
10.2 Pneumoconiosis Key Players in India
10.3 India Pneumoconiosis Market Size by Type
10.4 India Pneumoconiosis Market Size by Application

11 Central & South America
11.1 Central & South America Pneumoconiosis Market Size (2014-2019)
11.2 Pneumoconiosis Key Players in Central & South America
11.3 Central & South America Pneumoconiosis Market Size by Type
11.4 Central & South America Pneumoconiosis Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pneumoconiosis Introduction
12.1.4 Novartis Revenue in Pneumoconiosis Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pneumoconiosis Introduction
12.2.4 Abbott Revenue in Pneumoconiosis Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pneumoconiosis Introduction
12.3.4 Eli Lilly Revenue in Pneumoconiosis Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Sunpharma
12.4.1 Sunpharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pneumoconiosis Introduction
12.4.4 Sunpharma Revenue in Pneumoconiosis Business (2014-2019)
12.4.5 Sunpharma Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pneumoconiosis Introduction
12.5.4 Sanofi Revenue in Pneumoconiosis Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Novo Nordisk
12.6.1 Novo Nordisk Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pneumoconiosis Introduction
12.6.4 Novo Nordisk Revenue in Pneumoconiosis Business (2014-2019)
12.6.5 Novo Nordisk Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pneumoconiosis Introduction
12.7.4 AstraZeneca Revenue in Pneumoconiosis Business (2014-2019)
12.7.5 AstraZeneca Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details